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Abstract 
 
Purpose Low yield of invasive coronary angiography and unnecessary coronary interventions have 
been identified as key cost drivers in cardiology for evaluation of coronary artery disease (CAD). This 
has fuelled the search for non-invasive techniques providing comprehensive functional and anatomic 
information on coronary lesions. We have evaluated the impact of implementation of a novel hybrid 
Cadmium-Zinc-Telluride (CZT)/64-slice CT camera into daily clinical routine on downstream 
resource utilization. 
Methods Sixty-two patients with known or suspected CAD were referred for same-day single-session 
hybrid evaluation with CZT myocardial perfusion imaging (MPI) and coronary CT angiography 
(CCTA). Hybrid MPI/CCTA images from the integrated CZT/CT camera served for decision making 
towards conservative versus invasive management. Based on the hybrid images patients were 
classified into those with and those without matched findings. Matched findings were defined as the 
combination of MPI defect with a stenosis by CCTA in the coronary artery subtending the respective 
territory. All patients with normal MPI and CCTA, as well as those with isolated MPI or CCTA 
finding or combined but unmatched findings were categorized as “no match”. 
Results All 23 patients with a “matched” finding underwent invasive coronary angiography and 21 
(91%) were revascularized. Of the 39 patients with “no match” 5 (13%, p<0.001 vs. “matched”) 
underwent catheterization and 3 (8%, p<0.001 vs. “matched”) were revascularized. 
Conclusions Cardiac hybrid imaging in CAD evaluation has a profound impact on patient 
management and may contribute to optimal downstream resource utilization. 
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Introduction 
 
In clinical practice diagnosis of coronary artery disease (CAD) has been based on the presence of a 
luminal narrowing of greater than 50 % documented by invasive coronary angiography catheterization 
(CATH). However, it has been recognized over the last decade that many factors other than lumen size 
and its narrowing which cannot be comprehensively elucidated by coronary angiography alone may 
determine whether or not an anatomic coronary lesion induces ischemia. Therefore, decision-making 
towards revascularization without proof of ischemia has been recently challenged. In fact, modern 
guidelines for coronary revascularization [1] stipulate that comprehensive evaluation including proof 
of ischemia is mandatory for prognostically relevant target vessel revascularization in chronic stable 
CAD.  
Nuclear myocardial perfusion imaging (MPI) is a well-established method for the evaluation of 
myocardial ischemia and coronary computerized tomography angiography (CCTA) has been 
established over the past years as a clinical tool for the assessment of coronary anatomy. The 
combination of MPI with CCTA has been found to be a valuable gate-keeper for invasive coronary 
angiography [2] and may help to increase the low yield of elective invasive diagnostic coronary 
angiography (currently less than 40%) [3]. Cardiac hybrid imaging has emerged as one of the latest 
methodological advancements, integrating information on anatomy (CCTA) with that from MPI into 
hybrid images [4]. This allows to directly relating individual myocardial perfusion territories to the 
subtending coronary arteries. Most studies on hybrid MPI/CT imaging are based on fusion of data 
from a separate gamma camera and a standalone CT-scanner, as the unfavourable discrepancy of scan 
length (short CT and long MPI acquisition time) was hampering the widespread use of hybrid 
SPECT/CT devices in daily clinical routine. With the introduction of new gamma cameras using 
Cadmium-Zinc-Telluride (CZT) detector technique [5-8], scan time has been reduced substantially 
down to few minutes [9, 10]. This has paved the way for hybrid SPECT/CT scanners integrating a 
CZT gamma camera with a high end 64-slice CT device and has increased the interest in cardiac 
fusion imaging, further supported by recent results confirming the diagnostic strength [4, 11] and the 
prognostic value [12] of cardiac hybrid imaging. However, data on the added clinical value of hybrid 
 4
cardiac CZT/CT imaging in the decision making for the appropriate treatment strategy is lacking. The 
aim of the present study was to evaluate in daily clinical routine the impact of hybrid cardiac MPI and 
CCTA imaging obtained with an integrated ultrafast CZT/CT device on downstream resource 
utilisation such as invasive coronary angiography and revascularization. 
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Material and Methods 
 
Patients and Study Protocol 
We included 62 patients without history of prior coronary artery bypass graft (CABG) who were 
consecutively referred for the assessment of known or suspected CAD for a same-day single-session 
hybrid scan with CZT myocardial perfusion imaging (MPI) and CCTA to obtain hybrid cardiac 
images. All patients were scanned on a CZT/64-slice CT hybrid camera (Discovery NM/CT 570c, GE 
Healthcare) and the integrated CZT/CT images were reported to the referring physicians who made a 
decision towards invasive CATH versus conservative management based on the hybrid imaging 
finding on the one side and including the clinical history and the symptoms on the other hand. 
Similarly, in the catheterization laboratory the interventional cardiologist based his/her decision 
towards revascularization on the hybrid images and the clinical history, integrating the angiographic 
findings including fractional flow reserve at the operators’ discretion into the clinical decision-making. 
Downstream resource utilization within 60 days triggered by the hybrid imaging was assessed 
including: decision for conservative treatment, invasive angiography, and revascularization procedure 
(CABG or percutaneous coronary intervention, PCI). From each study participant written informed 
consent was obtained for the use of their imaging and clinical data for research purposes as approved 
by the institutional review board. 
 
Image Acquisition 
All patients underwent one-day pharmacological stress/rest SPECT-MPI protocol according to the 
guidelines of the European Association of Nuclear Medicine [13] with adenosine (0.14 mg/kg/min 
over 6 min) while in patients with contraindications to adenosine (n=16) we used dobutamine 
(incrementally administered, starting at 5 µg/kg per minute and increasing at 1 minute intervals to a 
maximal dose of 60 µg/kg per minute until 85% of the age-predicted heart rate had been achieved) 
according to daily clinical routine in our lab. Approximately 60 minutes after injection of 99mTc-
tetrofosmin (332±36 MBq), stress MPI images were acquired (5 minutes) using the CZT/CT camera. 
This was followed by acquisition of rest MPI with the identical acquisition protocol several minutes 
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[14] after administration of a three times higher dose of 99mTc-tetrofosmin (955±169 MBq). MPI scans 
were acquired using a multipinhole collimator (effective diameter aperture of 5.1 mm) and 19 
stationary detectors simultaneously imaging 19 different views of the heart as previously reported. In 
brief, each detector contains 32 x 32 pixelated (2.46 x 2.46 mm) CZT elements; the system design 
allows acquisition without detector or collimator motion, and a 10% symmetrical energy window at 
140 keV was used [9]. A low-dose CT scan was performed for attenuation correction of SPECT-MPI, 
which also allows calculation of calcium scoring [15]. Thereafter, all patients underwent contrast-
enhanced CCTA with prospective ECG-triggering as previously reported [16-18]. Intravenous 
metoprolol (2.5 to 25 mg) was administered prior to the examination if necessary in order to obtain 
optimal image quality for CCTA (target heart rate <65 bpm). All patients received 2.5 mg 
isosorbiddinitrate sublingually 2 min prior to the CCTA scan. MPI and CCTA images were fused on a 
dedicated workstation (Advantage Workstation 4.3, GE Healthcare) projecting the MPI images on the 
left ventricular epicardial surface obtained from the CCTA using the CardIQ Fusion software package 
(GE Healthcare) as previously validated [19, 20]. The 3D volume rendered fusion images enable a 
panoramic view of the coronary artery tree projected onto the left ventricular myocardial perfusion 
territories. Cardiac hybrid images can be displayed in standard anterior, posterior, lateral and apical 
view and in freely selectable angles for standardized documentation and reporting. Effective radiation 
dose for CCTA was calculated from dose-length product (DLP) using a conversion coefficient for the 
chest k=0.014 mSv/(mGy x cm); for SPECT-MPI a conversion factor of 0.0079 mSv/MBq was used.  
 
Cardiac Hybrid Image Interpretation 
Fused MPI and CCTA images were analysed by two experienced nuclear cardiologists by consensus 
with regard to functionally relevant coronary stenoses. For each patient, myocardial tomograms were 
grouped into 20 segments. The following 5-point scoring system was used to grade the segmental 
radionuclide uptake: 0 = normal, 1 = equivocal, 2 = moderate, 3 = severe reduction of radioisotope 
uptake, 4 = absence of detectable tracer in a segment. A pathologic scan was defined as one with stress 
score ≥ 2 in two or more segments. If a stress defect was associated with a stress defect score of 4 with 
a rest score of 2 or a rest score ≤ 1, a scan was classified as reversible perfusion defect. As patient 
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management should be ischemia-driven according to best clinical practice only reversible defects were 
considered for the following assignment into “matched” vs. “no matched” finding. A matched 
SPECT/CT hybrid cardiac imaging finding was defined as a reversible SPECT-MPI defect in a 
territory served by a coronary artery with a stenosis (defined as narrowing of the coronary luminal 
diameter ≥ 50%, Fig. 1). All patients with normal SPECT and CCTA, as well as those with isolated 
CCTA or MPI finding or combined but anatomically unmatched finding were categorized as “no 
match”.  
 
Invasive Coronary Angiography Data Acquisition and Analysis 
Invasive CATH was performed according to clinical standards by experienced interventional 
cardiologists. Segmentation of the coronary artery tree was performed as described for CCTA. A 
coronary stenosis was defined as a luminal narrowing ≥ 50%. This was based on visual assessment 
reflecting clinical routine in our and most other catheterization laboratories worldwide [21, 22]. The 
fractional flow reserve (FFR) was determined as the ratio of the simultaneously assessed pressure in 
the aorta and in the coronary artery distal of a stenosis during maximal hyperaemia (induced by 
intravenous adenosine administration via a central vein at 140 µg/kg/min) [22]. 
 
Statistical Analysis 
Quantitative variables were expressed as mean ± standard deviation and categorical variables as 
frequencies or percentages. SPSS 19.0 (SPSS, Chicago, IL) was used for statistical analysis. Chi-
square test was applied to compare the revascularization rates between the two different patient 
groups. P values from chi square test of less than 0.05 were considered statistically significant. 
 8
Results 
 
All patients (n=62) successfully underwent stress/rest CZT-MPI and CCTA using the CZT/CT 
camera. The patient characteristics are given in Table 1. 
Overall, the CATH rate was 43% in the study population yielding 96%. CZT revealed 32 patients 
(52%) with an abnormal MPI with reversibility in 26 patients, while CCTA documented a coronary 
stenosis in 42 patients (68%) excluding CAD in 20 patients (32%). Three cases with (false) positive 
SPECT were corrected into negative by normal CCTA findings. Conversely, a coronary stenosis ≥ 
50% in CCTA but without stress-induced regional perfusion defect was found in 17 patients while 19 
patients had a normal finding in both CCTA and MPI. Cardiac hybrid imaging revealed a matched 
perfusion defect in 23 patients (38%) whereas 39 patients (63%) had no matched findings. The 
measurement of FFR was performed in 9 patients (in 12 coronary lesions). 
During follow-up, all patients with matched cardiac hybrid findings (n=23) were referred to CATH of 
whom 21 (91%, Fig. 2) subsequently underwent percutaneous coronary intervention (PCI) or coronary 
artery bypass grafting (CABG). Of the two patients without revascularization one had normal coronary 
arteries by CATH and the second patient had a small MPI defect and invasive assessment revealed a 
stenosis with normal fractional flow reserve (FFR ≥ 0.8) over two lesions, i.e. in the left anterior 
descending artery (0.82) and in the left circumflex artery (0.89) both of which did therefore not qualify 
for coronary revascularization [23]. Only 5 of the 39 patients (13%) with no matched hybrid finding 
(Fig. 2) were sent to CATH and 3 (8%) were revascularized. The reasons for referring patient to 
CATH without matched hybrid finding were either severe CAD (left main or three vessel disease) ≥ 
80% (n=2) or massively elevated Agatston coronary calcium scoring (> 1000; n=3). The latter has 
recently been shown to unmask obstructive CAD in patients with normal SPECT-MPI [24]. 
Revascularization was subsequently performed in three patients despite lack of matched finding as one 
patient revealed abnormal FFR over a lesion in the left anterior descending artery (0.69) and the other 
patients showed either severe coronary three vessel disease or severe stenosis of the left main artery. 
There was a significantly lower downstream CATH resource utilization in patients with no matched 
findings versus those patients with matched cardiac hybrid findings (p<0.001). Due to sublinical CAD 
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(< 50% luminal narrowing) preventive medical intervention was installed in one patient, while in one 
patient such medication was withdrawn after excluding any lesion by CCTA. 
The effective radiation dose for stress/rest SPECT-MPI was 10.2±1.5 mSv, for attenuation correction 
0.9±0.1 mSv and for prospective triggered CCTA 1.8±0.6 mSv.  
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Discussion 
 
Our results demonstrate that cardiac hybrid imaging with a CZT/CT device allows efficient 
comprehensive evaluation of CAD. This has a profound impact on patient management and may 
contribute to optimal downstream resource utilization. In the present study we have shown that in 91% 
of patients with a matched finding in cardiac hybrid imaging coronary revascularization was 
performed whereas only 8% of patients without matched cardiac hybrid finding were revascularized.  
With regard to resource utilization the use of hybrid imaging had a strong impact as 100% of patients 
with a match but only 13% of patients without match were referred to CATH. As a result, in the 
patient group with a match the CAD per CATH yield was 96% comparing favourably to the yield of 
less than 38% recently reported for a similar elective large population [3]. The high CAD yield in our 
study paved the way for the above mentioned high rate of revascularization per CATH (91%), which 
is far superior to figures reported in registries of most European countries, such as for example 
Germany (36%) [25].  
An appropriate selection of patients who will benefit from invasive CATH and eventually from 
revascularization is crucial not only because of the costs of CATH but also because of its non-
negligible rate of procedural in hospital morbidity and mortality [26, 27]. Although it has been for 
long time suggested [28] and repeatedly documented [22] that for best clinical practice functional 
assessment of coronary lesion is mandatory, invasive CATH has remained not only the gold standard 
for CAD detection but also for decision-making for or against need of revascularization. Our results 
show that hybrid cardiac imaging is an excellent gate keeper for further evaluation with CATH. In 
fact, the high yield of CAD and revascularization rate per CATH documents an appropriateness of 
invasive resource utilization far beyond that reported from large clinical routine registries [3, 25]. By 
contrast, resource utilization was very low in patients with no hybrid match, in whom decision towards 
invasive CATH (n=5) was mainly driven by extensive coronary calcification (> 1000 Agatston units), 
which has recently been shown to unmask CAD in patients without SPECT-MPI abnormalities. 
Therefore, in the present study a calcium score > 1000 triggered a CATH overruling the lack of a 
matched finding. In 3 of these 5 patients justification to revascularize was supported either by FFR or 
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the presence of severe multi-vessel disease including main stem involvement [2]. The clinical value of 
comprehensive CAD assessment by hybrid CZT/CT imaging lies in the improvement of evidence-
based patient selection for coronary revascularization [12, 29]. Although coronary interventions have 
shown to successfully reduce ischemic symptoms and, therefore, improve patients’ quality of life, 
periprocedural adverse events remain important considerations, particularly in low risk populations. In 
stable CAD populations revascularizations have failed to confer a prognostic superiority compared to 
optimal medical therapy [30-33]. However, in patients with moderate to large ischemia 
revascularization may be the most effective strategy to reduce the amount of jeopardized myocardium 
and, consequently, improve prognosis [34]. As hybrid findings have shown to be superior in predicting 
adverse events over isolated findings [12] it appears appropriate that these findings are the 
predominant target of revascularization. In this context our results show that the implementation of 
hybrid CZT/CT camera in daily clinical routine confers an added value for evidence-based decision 
making and optimization of adequate downstream resource utilization. Patients with intermediate to 
high pre-test probability are among those who most likely may benefit from non-invasive evaluation 
by hybrid imaging. However, in view of the fact that most patients referred to elective invasive 
coronary angiography reveal normal coronary arteries, even lower pre-test probability patients may be 
candidates for a hybrid approach as long as unnecessary invasive angiographies can be avoided. A 
larger study would be needed to provide final proof of cost-effectiveness of the hybrid method, which 
was beyond the scope of the present pilot study. 
We acknowledge the following limitations: A potential limitation of the present study is the fact that 
all patients underwent two non-invasive tests cumulating radiation exposure to the patients. However, 
several algorithms may be implemented into hybrid imaging such as for example stress only MPI [35] 
to reduce radiation. In addition, CZT cameras offer the potential of a low-dose/low-dose one-day 
protocol as the count-rate linearity allows subtraction of the counts of the first scan avoiding the need 
for a 3-fold increase of the second scan [36]. Finally, although patients were included consecutively, 
there was no randomization to different treatment options due to the observational nature of this pilot 
study on the downstream resource utilization. However, our results support the notion that use of a 
CZT/CT hybrid device in daily clinical routine may favourably affect resource utilization. 
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Nevertheless this may also depend on the awareness of the clinicians about the availability and 
performance of hybrid imaging as well as on the clinical environment accepting non-invasive imaging 
as guidance for revascularization. 
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Table and Figure Captions 
 
Table 1 Patient characteristics. 
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Fig. 1 Cardiac hybrid image and angiographic finding. Coronary artery stenosis (white arrow head) in 
proximal left anterior descending artery is shown in CCTA (A, multiplanar and B, curved multiplanar 
reconstruction), cardiac hybrid imaging with normal perfusion at rest (E) and perfusion defect at stress 
(C) matching the territory of the coronary artery with stenosis (white arrow head), and invasive 
coronary angiography (D) confirming the coronary stenosis (white arrow head). 
 
Fig. 2 Downstream resource utilization after cardiac hybrid imaging. CATH: invasive coronary 
angiography. 
 
